What are the risks of tigecycline overuse?
Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections. However, overuse of tigecycline has raised concerns regarding its impact on survival odds and antibiotic resistance.
How does tigecycline overuse contribute to antibiotic resistance?
Overuse of tigecycline can accelerate the development of antibiotic-resistant bacteria [1]. Tigecycline's broad-spectrum activity selects for resistant bacteria that can continue to proliferate, increasing the risk of infections that tigecycline cannot treat. According to [2], the overuse of tigecycline has contributed to the emergence of vancomycin-resistant Enterococci (VRE).
What are the consequences of tigecycline overuse on patient outcomes?
The consequences of tigecycline overuse on patient outcomes are multifaceted:
* Increased mortality rates: Studies have shown that tigecycline overuse is associated with higher mortality rates, particularly in patients with complex infections [3].
* Lengthened hospital stays: The use of tigecycline inappropriately can lead to longer hospital stays, increased healthcare costs, and a heavier burden on the healthcare system.
* Decreased effectiveness of tigecycline: Overuse of tigecycline can reduce its effectiveness against susceptible bacteria, rendering it less effective as a treatment option.
When does exclusivity expire for tigecycline?
Tigecycline's patent expired in 2018, making it available as a generic medication. However, its overuse continues to be a concern. As more generic versions of tigecycline become available, it's essential to monitor its use to prevent antibiotic resistance and ensure effective treatment options for patients.
Can biosimilars enter the market before patent expiry?
The development and approval of biosimilars, including those for antibiotics, are subject to regulatory guidelines [4]. While biosimilars can enter the market before the expiry of the original patent, their approval requires a thorough review of their safety and efficacy profiles. The introduction of biosimilars can increase competition and reduce costs, but its impact on tigecycline overuse remains to be seen.
What are the implications for future antibiotic research and development?
The overuse of tigecycline emphasizes the need for responsible antibiotic stewardship and targeted research in the development of new antibiotics. The discovery of new antibiotics with novel mechanisms of action can help mitigate the effects of tigecycline overuse and combat the growing threat of antibiotic resistance.
Sources:
[1] Centers for Disease Control and Prevention. (2020). Antibiotic Resistance Threats in the United States.
[2] Infectious Diseases Society of America. (2019). Emerging Infections: A Review of the Literature.
[3] European Centre for Disease Prevention and Control. (2018). Antimicrobial resistance in the EU/EEA.
[4] World Health Organization. (2020). Biosimilar medicines.